featured
Nivolumab Plus Ipilimumab for Advanced Salivary Gland Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
Nat. Med. 2023 Aug 24;[EPub Ahead of Print], JL Vos, B Burman, S Jain, CWR Fitzgerald, EJ Sherman, LA Dunn, JV Fetten, LS Michel, A Kriplani, KK Ng, J Eng, V Tchekmedyian, S Haque, N Katabi, F Kuo, CY Han, Z Nadeem, W Yang, V Makarov, RM Srivastava, I Ostrovnaya, M Prasad, CL Zuur, N Riaz, DG Pfister, CA Klebanoff, TA Chan, AL Ho, LGT MorrisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.